Company Filing History:
Years Active: 2009
Title: Innovations by Inventor Dexian Dou
Introduction
Dexian Dou is a notable inventor based in Livonia, MI (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions.
Latest Patents
Dexian Dou holds a patent for "Chromatin peptides blocking human HIF-1α gene and modulating the downstream related genes." This patent describes chromatin peptide drug molecules that can block the human cell hypoxia responsive pathway. These molecules are designed to bind specifically to the HIF-1α gene self-promoter or its downstream regulated gene promoters, which include more than 40 genes. The invention aims to permanently shut down molecular pathways involved in cell glycolysis reactions, immuno-inflammation reactions, or hypoxia responses. This innovative approach has the potential to halt the uncontrollable proliferation of later-stage tumor cells or chronic inflammation cells under hypoxic conditions. Dexian Dou has 1 patent to his name.
Career Highlights
Dexian Dou is currently associated with Geneblue Corporation, where he continues to advance his research and development efforts. His work focuses on creating solutions that address critical health challenges through innovative biotechnology.
Collaborations
Dexian Dou collaborates with esteemed colleagues, including Xiaozhuang Bian and Chengqiu Wang, to further enhance the impact of their research in the field.
Conclusion
Dexian Dou's contributions to biotechnology through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of diseases related to hypoxia and inflammation.